Global Orally Disintegrating Tablet Market Size By Type(Anti-Psychotics drugs, Anti-Epileptics drugs), By Application(CNS Diseases, Gastrointestinal Diseases, CVS Diseases), By Geographic Scope And Forecast

Orally Disintegrating Tablet Market Size And Forecast

Orally Disintegrating Tablet Market size was valued at USD 16,043.2 Million in 2022 and is projected to reach USD 34,893.4 Million by 2030, growing at a CAGR of 10.20% from 2023 to 2030.

Tablets that dissolve fast in the mouth and deliver desired medicines with good patient compliance are the best options for people. For both patients and doctors, the oral route of administration is a practical and appropriate dosage type. The demand for ODT, which can dissolve in a minute, is increased by oral route administration with a quick beginning of the effect. These factors should drive the expansion of the ODT market. The Global Orally Disintegrating Tablet Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Orally Disintegrating Tablet Market Definition

An orally disintegrating tablet or orally dissolving tablet (ODT) is a medicine dosage form that is available for a small selection of both prescription and over-the-counter (OTC) medications. Traditional tablets are meant to be swallowed whole, but ODTs are meant to be completely dissolved on the tongue. For patients who have dysphagia (difficulty swallowing), or for those for whom compliance is a known problem, the ODT is a substitute dosage form that helps ensure that medication is taken.

Dysphagia is a common condition that affects people of all ages, affecting up to 60% of old people living in institutions and between 18 and 22% of all patients in long-term care facilities. ODTs have the convenience of a tablet that may be taken without water and may start working more quickly than tablets or capsules. ODTs have become accessible in a number of therapeutic markets over the past ten years, both over-the-counter and by prescription. The ODT had its origins in tablets made to dissolve on the buccal (cheek) mucous membrane. This dose form was created for medications like steroids and opioid analgesics that have poor absorption via the digestive system but are difficult to provide parenterally.

The medicine can bypass the digestive system through cheek absorption for quick systemic distribution. Not all ODTs have buccal absorption, and many have absorption and bioavailability that are comparable to those of conventional oral dose forms, with GI absorption still being the predominant route. However, a quick disintegration period and a little tablet weight can improve buccal absorption. The early ODTs, created to help youngsters more comfortable ingesting vitamins, dissolved by effervescence rather than dissolution. The development of microparticles holding drugs that would release upon the tablet’s effervescence and be inhaled by the patient allowed for the adaptation of this technique for use in medicine.

Global Orally Disintegrating Tablet Market Overview

The aging population is growing as life expectancy is increasing. Moreover, the survival rate of persons with chronic conditions has grown due to the availability of cutting-edge medical facilities and scientific developments in medicine. For the elderly to finish a medicine course, oral disintegrating pills are the perfect option. In turn, this is anticipated to fuel market expansion. In addition, as compared to other dose forms, ODTs are appropriate dosage forms for people with mental disabilities. Such individuals are simple to persuade to take this dosage type because of its rapid beginning of the action, which gives them immediate relief. The market is anticipated to grow as oral disintegrating pills are increasingly used to treat a variety of illnesses in mentally disabled people.

Additionally, people with a variety of illnesses, including Parkinson’s, Alzheimer’s, lung, renal, diabetes, stroke, heart, heart disease, allergies, and GI issues, must take various medications for a considerable amount of time. For post-operative treatment, doctors recommend oral drugs to their patients. Tablets that dissolve fast in the mouth and deliver desired medicines with good patient compliance are the best options for people. For both patients and doctors, the oral route of administration is a practical and appropriate dosage type. The demand for ODT, which can dissolve in a minute, is increased by oral route administration with a quick beginning of the effect. These factors should drive the expansion of the ODT market.During the projected period, the rising adoption of technologically improved goods and dosage forms for advanced treatment choices in developing economies is anticipated to increase demand for ODTs. Access to healthcare and raising the standard of treatment in developing nations are anticipated to open up prosperous business chances for manufacturers there.

Global Orally Disintegrating Tablet MarketSegmentation Analysis

The Global Orally Disintegrating Tablet Market is segmented based on Type, Application, and Geography.

Orally Disintegrating Tablet Market, By Type

• Anti-Psychotics Drug• Anti-Epileptics Drug• Other

Based on Type, the market is bifurcated into Anti-Psychotics drugs, Anti-Epileptics drugs, and Others. The anti-psychotics segment is expected to hold a 7.5% share of the market in 2022. The growing prevalence of psychotic disorders such as schizophrenia and bipolar disorder is projected to increase the demand for antipsychotic drugs.

Orally Disintegrating Tablet Market by Application

• CNS Diseases• Gastrointestinal Diseases• CVS Diseases• Others

Based on Application, the market is bifurcated into CNS Diseases, Gastrointestinal Diseases, CVS Diseases, and Others. The central nervous system diseases segment is estimated to account for a significant market share in 2022, due to the increasing prevalence of CNS diseases across the world.

Orally Disintegrating Tablet Market by Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of a Geographical Analysis, the Global Orally Disintegrating Tablet Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia Pacific is expected to remain a highly attractive region for the orally disintegrating tablets market as well as is projected to expand at a high CAGR during the forecast period. The region is expected to dominate the global market, in terms of value and volume, due to the use of ODTs to reduce the prevalence of several disorders such as CND, GI disorders, CVDs, and allergies.

Key Players

The “Orally Disintegrating Tablet Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer, and others are prominent hydro turbine manufacturers operating the market.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Orally Disintegrating Tablet Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Orally Disintegrating Tablet Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors.• Provision of market value (USD Billion) data for each segment and sub-segment.• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market.• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region.• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled.• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions.• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis.• Provides insight into the market through Value Chain.• Market dynamics scenario, along with growth opportunities of the market in the years to come.• 6-month post-sales analyst support.

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.